The first partnership agreement between the Royal Pharmaceutical Society and Harper Adams University College has been signed to provide pharmacy graduates with specialist courses in veterinary pharmacy and to enable their continuing professional development...

Chemaphor (TSX VENTURE:CFR), a biotechnology company specializing in the development of health products for enhancing and maintaining the wellness of animals, is pleased to announce it has completed its first clinical trial to evaluate the efficacy of an oral OximunolTM supplement in promoting overall health and well-being of companion canines...

In the new Swedish-Finnish study, published in Nature Genetics, the researchers identified five loci that predispose to an SLE-related disease in Nova Scotia duck tolling retrievers. The study indicates that the homogeneity of strong genetic risk factors within dog breeds make dogs an excellent model in which to identify pathways involved in human complex diseases...

Effective January 31, 2010, equine owners, intending to sell animals directly or indirectly to Canadian meat processors, are being advised to record certain information. Equine owners who wish to keep their sale options open should record all vaccines, medications given (administered or fed) to their animals and record any occurrence of illness in their animals...

The British Veterinary Association (BVA) has launched a guidance poster containing powerful messages to vets to encourage the responsible use of anthelmintics in grazing animals, following ongoing concern about the development of resistance to these medicines...

VGX Animal Health, Inc. announced that data demonstrating the effectiveness of its plasmid-based growth hormone releasing hormone (pGHRH) technology was recently published in the peer-reviewed journal Molecular Therapy in a paper entitled, "A Comparison of the Growth Responses Following Intramuscular GHRH Plasmid Administration Versus Daily Growth Hormone Injections in Young Pigs...